Q3 2024 Holdings
Filed 2024-11-14 | 42 holdings | $520.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $81.5M | 4,415,689 | 15.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $61.5M | 5,074,916 | 11.8% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $54.4M | 6,788,609 | 10.5% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $53.2M | 1,267,790 | 10.2% |
| Alumis Inc(ALMS) | COMMON STOCK | 022307102 | $34.9M | 3,266,498 | 6.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $29.5M | 353,641 | 5.7% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $28.7M | 1,208,473 | 5.5% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $17.0M | 3,768,035 | 3.3% |
| Eliem Therapeutics Inc(CLYM) | COM | 28658R106 | $13.3M | 2,609,114 | 2.6% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $12.7M | 967,527 | 2.4% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $12.6M | 1,000,000 | 2.4% |
| Acelyrin Inc | COM | 00445A100 | $12.4M | 2,523,022 | 2.4% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $11.3M | 588,816 | 2.2% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $11.0M | 584,642 | 2.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $9.8M | 850,000 | 1.9% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $9.0M | 172,647 | 1.7% |
| Inozyme Pharma Inc | COM | 45790W108 | $8.2M | 1,562,500 | 1.6% |
| Sutro Biopharma Inc | COM | 869367102 | $7.6M | 2,196,814 | 1.5% |
| Leap Therapeutics Inc(CYPH) | COM NEW | 52187K200 | $6.3M | 2,442,352 | 1.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $6.0M | 6,130,268 | 1.2% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $5.6M | 195,225 | 1.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $4.9M | 630,000 | 0.9% |
| Artiva Biotherapeutics Inc(ARTV) | COMMON STOCK | 04317A107 | $4.5M | 291,666 | 0.9% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $3.8M | 1,786,427 | 0.7% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $3.8M | 3,640,015 | 0.7% |
| VTV Therapeutics Inc(VTVT) | CL A NEW | 918385204 | $2.8M | 206,784 | 0.5% |
| Immatics N.v(IMTX) | SHS | N44445109 | $2.3M | 198,000 | 0.4% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $2.1M | 540,304 | 0.4% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $2.1M | 147,319 | 0.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $1.7M | 202,348 | 0.3% |
| Hillevax Inc | COM | 43157M102 | $1.4M | 799,274 | 0.3% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $1.0M | 22,526 | 0.2% |
| Bicara Therapeutics Inc(BCAX) | COMMON STOCK | 055477103 | $891.5K | 35,000 | 0.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $800.6K | 696,171 | 0.2% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $714.5K | 2,780,261 | 0.1% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $679.9K | 1,049,153 | 0.1% |
| Viracta Therapeutics Inc | COM | 92765F108 | $159.6K | 689,709 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $112.4K | 172,089 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $78.1K | 78,131 | 0.0% |
| Allovir Inc | COM | 019818103 | $66.6K | 82,336 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $13.1K | 133,333 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $1.0K | 99,999 | 0.0% |